Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized clinically by rapidly progressive paralysis leading ultimately to death from respiratory failure. There is substantial evidence suggesting that ALS is a heritable disease, and a number of genes have been identified as being causative in familial ALS. In contrast, the genetics of the much commoner sporadic form of the disease is poorly understood and no single gene has been definitively shown to increase the risk of developing ALS. In this review, we discuss the genetic evidence for each candidate gene that has been putatively associated with increased risk of sporadic ALS. We also review whole genome association studies of ALS and discuss the potential of this methodology for identifying genes relevant to motor neuron degeneration.

Original publication

DOI

10.1093/hmg/ddm215

Type

Journal article

Journal

Hum Mol Genet

Publication Date

15/10/2007

Volume

16 Spec No. 2

Pages

R233 - R242

Keywords

Amyotrophic Lateral Sclerosis, Aryldialkylphosphatase, Cyclic AMP Response Element-Binding Protein, DNA-(Apurinic or Apyrimidinic Site) Lyase, Dynactin Complex, Endosomal Sorting Complexes Required for Transport, Hemochromatosis Protein, Histocompatibility Antigens Class I, Humans, Intercellular Signaling Peptides and Proteins, Intermediate Filament Proteins, Membrane Glycoproteins, Membrane Proteins, Microtubule-Associated Proteins, Nerve Degeneration, Nerve Tissue Proteins, Neurofilament Proteins, Peripherins, RNA-Binding Proteins, Ribonuclease, Pancreatic, SMN Complex Proteins, Superoxide Dismutase, Superoxide Dismutase-1, Vascular Endothelial Growth Factor A